Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/12/1999US5965125 Hybrid matrix implants and explants
10/12/1999US5965124 Replication-competent recombinant viral vaccines and method of producing same
10/12/1999US5965123 Coated pesticidal agents, processes for their preparation and compositions containing them
10/12/1999US5965122 Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors
10/12/1999US5965120 Lymphocyte chemoattractant factor and uses thereof
10/12/1999US5965108 Cyclic peptide-metal complex specifically binds to surface somatostatin receptor-expressing cells; radiology; scintigraphy; antitumor,-carcinogenic and metastatic agents; stability
10/12/1999US5965107 Electrically neutral complex comprising radioactive technetium, peptide, radiolabel binding moiety; radiolabelled peptide for medical diagnostic imaging
10/12/1999CA2096851C Tissue plasminogen activator substitution variant
10/12/1999CA1340787C Cdnas coding for members of the carcinoembryonic antigen family
10/12/1999CA1340781C Tumor specific monoclonal antibodies
10/10/1999CA2263059A1 New peptide compounds analogue to glucagon-like-peptide-1 (7-37), their preparation process and the pharmaceutical compositions containing them
10/07/1999WO1999050670A1 Pf-4 receptor assay
10/07/1999WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999WO1999050658A2 Methods and compounds for modulating nuclear receptor activity
10/07/1999WO1999050657A1 Corticotropin releasing factor receptor 1-deficient mice
10/07/1999WO1999050637A2 Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof
10/07/1999WO1999050461A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999WO1999050435A1 Gpi-122, a novel glycophosphatidylinositol-anchored protein
10/07/1999WO1999050432A1 Inducible alphaviral gene expression system
10/07/1999WO1999050427A2 Novel basal endosperm transfer cell layer (betl) specific genes
10/07/1999WO1999050424A2 Fusion protein comprising a sequence from a major coat protein of a papovavirus
10/07/1999WO1999050419A2 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
10/07/1999WO1999050418A1 Treatment and diagnosis of staphylococcal infections
10/07/1999WO1999050417A1 Novel sequence class of genes, corresponding proteins and the use of the same
10/07/1999WO1999050416A1 Tnf-related death ligand
10/07/1999WO1999050415A2 Protease-activated receptor par4 (zchemr2)
10/07/1999WO1999050414A1 Blk genes, gene products and uses thereof in apoptosis
10/07/1999WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY
10/07/1999WO1999050412A1 HUMAN p51 GENES AND GENE PRODUCTS THEREOF
10/07/1999WO1999050410A1 Novel molecules expressed during muscle development and genetic sequences encoding the same
10/07/1999WO1999050408A1 Novel gene that is amplified and overexpressed in cancer and methods of use thereof
10/07/1999WO1999050406A2 Growth differentiation factor-9 regulatory sequences and uses therefor
10/07/1999WO1999050405A1 Secreted proteins and polynucleotides encoding them
10/07/1999WO1999050404A2 Transgenic animals with inducible protein expression and methods of use
10/07/1999WO1999050390A1 Methionin containing animal cell culture medium and its use
10/07/1999WO1999050387A1 Vaccination modalities
10/07/1999WO1999050303A2 Immune response modulator alpha-2 macroglobulin complex
10/07/1999WO1999050302A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
10/07/1999WO1999050301A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999WO1999050299A1 Receptors
10/07/1999WO1999050298A1 GFRα-X, A NOVEL GLIAL-DERIVED NEUROTROPHIC FACTOR RECEPTOR AND USES THEREFOR
10/07/1999WO1999050297A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999WO1999050296A1 Treatment and prevention of vascular disease
10/07/1999WO1999050295A2 Agouti-related protein analogs and methods of use
10/07/1999WO1999050294A1 Novel hemolytic active proteins and genes encoding the same
10/07/1999WO1999050293A1 Chimeric insecticidal protein and gene coding therefore
10/07/1999WO1999050291A1 Retrovirus envelope gylcoprotein mutants and biological applications
10/07/1999WO1999050290A1 Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf)
10/07/1999WO1999050289A2 Transformation progression-related genes and their use
10/07/1999WO1999050288A2 Mammalian blood loss-induced gene, kd312
10/07/1999WO1999050287A2 P40 protein acts as an oncogene
10/07/1999WO1999050286A2 Antioxidant peptides derived from apolipoprotein a-iv
10/07/1999WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999WO1999050284A2 Nucleic acid molecules which code proteins influencing bone development
10/07/1999WO1999050283A1 High throughput screening assays for modulators of stat4 and stat6 activity
10/07/1999WO1999050282A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999WO1999050281A2 Collagen peptides and uses thereof
10/07/1999WO1999050280A1 Compositions and methods for controlling brca1-mediated p53-dependent and -independent regulation of transcription
10/07/1999WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999WO1999049898A1 Progression elevated gene-3 and uses thereof
10/07/1999WO1999049897A1 Hemoglobin-polysaccharide conjugates
10/07/1999WO1999049893A1 Methods for designing molecular conjugates and compositions thereof
10/07/1999WO1999049892A2 Use of active p40 conjugates for nasal delivery
10/07/1999WO1999049890A1 A preventive and therapeutic vaccine for helicobacter pylori-associated diseases
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049883A2 Oxidized thymosin beta 4
10/07/1999WO1999049881A2 Application of hsp70 proteins
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049735A1 Mpr-related abc transporter encoding nucleic acids and methods of use thereof
10/07/1999WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells
10/07/1999WO1999042575A3 Calcium-activated potassium channel beta subunit gene and protein
10/07/1999WO1999041614A3 Method for detecting intimin producing microorganisms
10/07/1999WO1999040197A3 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
10/07/1999WO1999040109A3 Recombinant mistletoe lectines
10/07/1999WO1999038888A3 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
10/07/1999WO1999037776A9 Methods for modulating angiogenesis
10/07/1999WO1999037768A9 Capon: a protein associated with neuronal nitric oxide synthase
10/07/1999WO1999035169A3 Methods and compositions for treating and diagnosing insulin related disorders
10/07/1999WO1999031273A3 Universal collection medium
10/07/1999WO1999031251A9 Method and means for producing high titer, safe, recombinant lentivirus vectors
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs
10/07/1999WO1999028465A3 Pias molecules that recognize and bind stat proteins and uses thereof
10/07/1999WO1999028461A3 Methods and means for inducing apoptosis by interfering with bip-like proteins
10/07/1999WO1999021996A9 Methods and compositions for the diagnosis and treatment of cataracts
10/07/1999WO1999015668A3 Banana proteins, dna, and dna regulatory elements associated with fruit development
10/07/1999DE19816395A1 Menschliche Nukleinsäuresequenzen aus Ovar-Normalgewebe Nucleic acid sequences from human ovarian normal tissue
10/07/1999DE19814925A1 Arzneimittel zur Induktion zytotoxischer T-Zellen Drugs for the induction of cytotoxic T cells
10/07/1999DE19814861A1 Neue Proteinvariante des NET1-Locus New protein variant of NET1 locus
10/07/1999DE19813760A1 Activation of natural killer cells to stimulate immune response, especially in treatment of tumors, infections and autoimmune diseases
10/07/1999DE19812941A1 Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor Medicines used to prevent or treat Papillomavirusspezifischem tumor
10/07/1999DE19812940A1 Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung Formulation with papillomavirus-specific protein, its preparation and use
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2327388A1 Retrovirus envelope gylcoprotein mutants and biological applications
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999CA2326000A1 Gpi-122, a novel glycophosphatidylinositol-anchored protein
10/07/1999CA2325984A1 Oxidized thymosin beta 4
10/07/1999CA2325735A1 Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation
10/07/1999CA2325721A1 Corticotropin releasing factor receptor 1-deficient mice
1 ... 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 ... 2916